By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CytoDyn 

1111 Main Street
Suite 660
Vancouver  Washington  98660  U.S.A.
Phone: 360-980-8524 Fax: 360-980-8549


SEARCH JOBS


Industry
Biotechnology






Company News
CytoDyn (CYDY) Release: Biotech Files For Breakthrough Therapy Designation With The FDA For PRO 140 In HIV Therapy 1/11/2017 7:07:50 AM
CytoDyn (CYDY) Announces Investment Community Conference Call For January 5, 2017 1/4/2017 7:17:32 AM
CytoDyn (CYDY) Reports Treatment Of First Several Patients With PRO 140 In Its Phase III Monotherapy Trial For HIV 12/12/2016 7:21:42 AM
CytoDyn (CYDY)’s Two-Year Update On Its PRO 140 Monotherapy Study In HIV Accepted At CROI 2017 11/16/2016 7:53:09 AM
CytoDyn (CYDY) Announces Webcast Of Investment Community Presentation On November 11 11/9/2016 7:27:27 AM
CytoDyn (CYDY) Files Protocol For Extended Access To PRO 140 For Patients Who Reach The End Of PRO 140 Pivotal Phase III Trial 10/24/2016 7:52:00 AM
bioMONTR Labs To Provide Testing Services For CytoDyn (CYDY) PRO 140 Clinical Trials 10/14/2016 11:52:46 AM
CytoDyn (CYDY) Announces Favorable Protocol Modifications For Pivotal Phase III Combination Trial With PRO 140 After Positive FDA Meeting 10/6/2016 7:07:08 AM
CytoDyn (CYDY) Announces $10.0 Million Registered Direct Offering 9/12/2016 7:55:21 AM
CytoDyn (CYDY) To Present At Rodman & Renshaw Global Investment Conference On September 12 9/8/2016 7:55:36 AM
12345678910...
//-->